What evidence is available on the safety of interferon gamma-1b during pregnancy?

For IMMUKIN (interferon gamma-1b), pregnancy data are inadequate, animal studies show reproductive toxicity and human risk is unknown; higher endogenous interferon gamma in women with recurrent first-trimester miscarriage versus normal pregnancy has no established clinical relevance to IMMUKIN, which should not be used during pregnancy unless vitally indicated.